window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 27, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Women in Pharma

Women in PharmaDebbie2026-02-23T12:09:55+00:00
  • Clinical studies,Digital Health,Global health,Mental health,Neurosciences

    Young adults in US, UK and Australia hit hardest by global mental health decline

    Young adults in wealthy countries are four times more likely [...]

    read more
  • Clinical studies,Digital Health,Drug Delivery & Formulation,Neurosciences

    Study confirms Nerivio REN wearable safe with continuous glucose monitoring devices

    A new study confirms that Theranica’s Nerivio REN wearable for [...]

    read more
  • Biotech,Drug Development,Drug discovery,Oncology

    Promatix shows 50-fold potency in colorectal cancer with PBS293 ADC

    Promatix Biosciences has reported preclinical data showing its cis-bispecific ADC [...]

    read more
  • Clinical Trials,Dermatology,Drug Development

    SolasCure phase 2 trial shows faster healing in venous leg ulcers

    SolasCure has reported positive phase 2 data for Aurase Wound [...]

    read more
  • Biotech,Clinical Development,Clinical Trials,Drug Development,Neurosciences,Pharmaceuticals and therapeutics,Research & Development

    AC Immune doses first participant in Phase 1 trial of NLRP3 inhibitor ACI-19764

    AC Immune has initiated a Phase 1 trial of its [...]

    read more
  • Biologics & Biosimilars,Biotech,Drug discovery,European biotech,Healthcare leadership,Movers & Shakers,Opthalmology,Research & Development

    Link Biologics appoints Niall Martin to board as TSG-6 pipeline advances towards clinic

    Link Biologics has appointed Niall Martin to its board as [...]

    read more
  • Biotech,Cell & Gene Therapy,Drug Development,Oncology

    etherna intratumoral mRNA/LNP platform advances toward IND studies in non-melanoma skin cancer

    etherna, a biotech company specialising in mRNA and lipid nanoparticle [...]

    read more
  • Artificial Intelligence,Digital Health,Funding,Healthcare leadership,Pharmaceuticals and therapeutics

    Brainomix extends Series C to $25.4M to support US expansion

    Brainomix has extended its Series C financing by $6.5M (£4.8M), [...]

    read more
  • Artificial Intelligence,Drug discovery,Precision medicine,Research & Development

    Promise Bio launches grant to support translational epiproteomics in biotech research

    Promise Bio has launched the Frontier Epiproteomic Innovation Grant, providing [...]

    read more
  • Cell & Gene Therapy,Drug discovery,Technology and platforms

    MaxCyte launches 96-well electroporation platform for cell therapy discovery

    MaxCyte, Inc. has launched ExPERT DTx, a 96-well electroporation platform [...]

    read more
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Almirall meets guidance with 12.4% net sales growth and dermatology portfolio progress in 2025
    Categories: Biologics & Biosimilars, Clinical studies, Dermatology, Pharmaceuticals and therapeutics
  • Abivax shows anti-fibrotic activity for obefazimod in IBD at ECCO 2026
    Categories: Biologics & Biosimilars, Clinical studies, Clinical Trials, Pharmaceuticals and therapeutics
  • Aspargo Labs appoints Sam Backenroth as chief financial officer to strengthen corporate and capital markets leadership
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Partnerships & Funding, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top